SCHEMBL24025637

SCHEMBL24025637

COC(=O)C1(C)CCN(S(=O)(=O)c2ccc(F)nc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.44
▸ ALDH1A1 P00352 5/20 0.44
▸ PKM P14618 1/20 0.43
▸ GAA P10253 2/20 0.41
▸ GLA P06280 1/20 0.40
▸ KMT2A Q03164 1/20 0.39
▸ F13A1 P00488 1/20 0.39
▸ TGM2 P21980 1/20 0.39
▸ TGM1 P22735 1/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ ATM Q13315 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ HPGD P15428 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HSD11B1 P28845 1/20 0.38
▸ CCR6 P51684 2/20 0.38
▸ MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24025489 0.78 AOC2 (0.49) —
SCHEMBL24058351 0.78 AOC2 (0.49) —
SCHEMBL23779174 0.77 PKM (0.64) ALDH1A1PKMKMT2AL3MBTL1HPGD
SCHEMBL26345593 0.77 PTGDR (0.40) KDM4EALDH1A1GAAKMT2AF13A1
SCHEMBL26284042 0.77 PTGDR (0.40) KDM4EALDH1A1GAAKMT2AF13A1
SCHEMBL24025490 0.75 ALDH1A1 (0.46) KDM4EALDH1A1PKMGAAKMT2A
SCHEMBL24025663 0.72 F13A1 (0.40) KDM4EALDH1A1F13A1TGM2TGM1
SCHEMBL24025665 0.72 F13A1 (0.42) KDM4EALDH1A1F13A1TGM2TGM1
SCHEMBL24025395 0.72 KDM4E (0.44) KDM4EALDH1A1PKMGAAKMT2A
SCHEMBL24057502 0.72 EPHX2 (0.50) ALDH1A1KMT2APOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3873599-B1 PYRIDINYL SULFONAMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INT (DE) 2023-09-27 — — EP disclosed
US-20210361637-A1 PYRIDINYL SULFONAMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2021-11-25 — — US disclosed
US-20210353608-A1 PYRIDINYL SULFONAMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2021-11-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210353608-A1 PYRIDINYL SULFONAMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF ARSA, SULT1A1, SULT2A1 KDM4E 3461/4885ALDH1A1 455/4885PKM 873/4885
US-20210361637-A1 PYRIDINYL SULFONAMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF ARSA, SULT1A1, SULT2A1 KDM4E 3461/4885ALDH1A1 455/4885PKM 873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback